Molina Healthcare, Inc $MOH Stock Holdings Lifted by Fifth Third Bancorp

Fifth Third Bancorp increased its position in shares of Molina Healthcare, Inc (NYSE:MOH) by 41.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,508 shares of the company’s stock after acquiring an additional 1,020 shares during the quarter. Fifth Third Bancorp’s holdings in Molina Healthcare were worth $1,045,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its stake in Molina Healthcare by 46.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock valued at $1,264,214,000 after purchasing an additional 1,216,903 shares during the period. T. Rowe Price Investment Management Inc. grew its holdings in shares of Molina Healthcare by 8.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock valued at $490,099,000 after buying an additional 117,796 shares in the last quarter. AQR Capital Management LLC raised its position in Molina Healthcare by 42.7% during the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock valued at $288,125,000 after buying an additional 264,664 shares during the period. GAMMA Investing LLC lifted its stake in Molina Healthcare by 74,593.7% in the 1st quarter. GAMMA Investing LLC now owns 667,015 shares of the company’s stock worth $219,708,000 after acquiring an additional 666,122 shares in the last quarter. Finally, Durable Capital Partners LP lifted its stake in Molina Healthcare by 13.1% in the 1st quarter. Durable Capital Partners LP now owns 541,605 shares of the company’s stock worth $178,399,000 after acquiring an additional 62,899 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Stock Performance

MOH opened at $192.35 on Monday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market cap of $10.43 billion, a PE ratio of 9.48 and a beta of 0.54. The stock has a 50-day moving average of $172.14 and a 200-day moving average of $256.53. Molina Healthcare, Inc has a 52-week low of $151.95 and a 52-week high of $359.97.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing analysts’ consensus estimates of $5.50 by ($0.02). The company had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The firm’s revenue was up 15.7% on a year-over-year basis. During the same period in the previous year, the business posted $5.86 earnings per share. As a group, equities research analysts forecast that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have weighed in on MOH. Barclays lowered their target price on Molina Healthcare from $186.00 to $185.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 4th. Mizuho lowered their price objective on shares of Molina Healthcare from $400.00 to $330.00 and set an “outperform” rating on the stock in a research report on Friday, July 11th. Truist Financial reiterated a “hold” rating and issued a $180.00 target price (down previously from $335.00) on shares of Molina Healthcare in a research report on Friday, July 25th. Cantor Fitzgerald reissued a “neutral” rating and set a $210.00 target price on shares of Molina Healthcare in a research note on Tuesday, August 26th. Finally, Wells Fargo & Company dropped their price target on shares of Molina Healthcare from $216.00 to $198.00 and set an “overweight” rating on the stock in a research note on Friday, August 15th. Three research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $225.18.

Insiders Place Their Bets

In other news, COO James Woys acquired 10,000 shares of the firm’s stock in a transaction that occurred on Monday, August 4th. The stock was acquired at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the acquisition, the chief operating officer owned 74,331 shares in the company, valued at approximately $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Ronna Romney sold 700 shares of the firm’s stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the transaction, the director owned 17,131 shares in the company, valued at $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.26% of the stock is currently owned by insiders.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.